|
 |
Mens Health > Erectile Dysfunction (Also Called Impotence.)
The following information is about Erectile Dysfunction (Also Called Impotence.).
Erectile Dysfunction (Also Called Impotence.) Defined
The inability to achieve an erection, and/or dissatisfaction with the size, rigidity, and/or duration of erections.
This definition is in context to Mens Health. See more contextual defintions for Erectile Dysfunction (Also Called Impotence.).
President Bush To Sign Bill Intended To Stop Operation Of Online Rogue Pharmacies
Published October 10, 2008, 2:06 pm, Medical News Today
President Bush is expected to sign into a law a bill (HR 6353, S 980) that aims to end the operation of online rogue pharmacies that sell controlled substances and pharmaceutical medicines, but the measure has "limitations," the Wall Street Journal reports (Rubenstein, Wall Street Journal, 10/9).
Watson Receives US FDA Approval For RAPAFLO(TM) (silodosin) For The Treatment Of Benign Prostatic Hyperplasia (BPH)
Published October 10, 2008, 3:07 am, Medical News Today
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved RAPAFLO(TM) (silodosin), the company's new alpha blocker for the treatment of the signs and symptoms of BPH.
Women's High Pitch Voice Points To Fertility
Published October 9, 2008, 7:44 am, Medical News Today
A woman's voice tends to rise in pitch the closer she is to ovulation according to research published today in the Royal Society Journal Biology Letters. Researchers believe this is because a higher pitch is more attractive and more feminine, thus signalling fertility to potential partners.
Low testosterone a problem in young diabetic men
Published October 9, 2008, 7:41 am, Reuters
NEW YORK (Reuters Health) - About one third of young adult men with type 2 diabetes have low testosterone levels, research shows.
Local Notes
Published October 9, 2008, 12:30 am, The Morning News
Reception Set For Hines A reception for longtime chiropractor Jerry Hines is planned for 4:30 p.m. Thursday at Club Frisco, 105 W. Poplar St. in Rogers.
TN Drug Control Dept to launch mass awareness programme with NPPA-CIFG
Published October 7, 2008, 7:48 pm, PharmaBiz
The Tamil Nadu Drugs Control Department will be organizing a mass awareness programme through the newly formed NPPA-CIFG against unhealthy practices in pharmaceutical sector such as marketing of spurious drugs and overpricing.
VIVUS Announces The Weight Loss Effects Of Qnexa In Type 2 Diabetes - Shows Weight Loss Of 17 Pounds In 28 Weeks
Published October 7, 2008, 9:22 am, Medical News Today
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr.
Researchers to Evaluate a Once-Daily Investigational Dose of Raltegravir, Merck's Integrase Inhibitor, in an ...
Published October 7, 2008, 9:19 am, PR Newswire via Yahoo! Finance
Daily Raltegravir Study to be Conducted in 21 Countries Worldwide
VIVUS Announces the Weight Loss Effects of Qnexa in Type 2 Diabetes
Published October 6, 2008, 9:57 am, Centre Daily Times
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr. Barbara Troupin, Senior Director of Clinical Development, announced the data in a poster presentation ...
VIVUS Announces the Weight Loss Effects of Qnexa in Type 2 Diabetes
Published October 6, 2008, 9:45 am, Business Wire via Yahoo! Finance
MOUNTAIN VIEW, Calif.----VIVUS, Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona.
Are you looking for additional Mens Health > Erectile Dysfunction (also Called Impotence.) news? Try our new "Erectile Dysfunction (also Called Impotence.) News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Erectile Dysfunction (Also Called Impotence.). If you would like to find related tags we recommend Tag Patterns > Erectile Dysfunction (Also Called Impotence.)
Off-site Erectile Dysfunction (also Called Impotence.) Research Links
If you still need additional information on Erectile Dysfunction (also Called Impotence.) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Erectile Dysfunction (Also Called Impotence.)
- Alexa > Erectile Dysfunction (Also Called Impotence.)
- Anti-Aging Revolution > Erectile Dysfunction (Also Called Impotence.)
- DMOZ > Erectile Dysfunction (Also Called Impotence.)
- Feeds Filtered > Erectile Dysfunction (Also Called Impotence.)
- Google > Erectile Dysfunction (Also Called Impotence.)
- News Meme > Erectile Dysfunction (Also Called Impotence.)
- Nuah: News > Erectile Dysfunction (Also Called Impotence.)
- The Feed Directory > Erectile Dysfunction (Also Called Impotence.)
- OBP > Erectile Dysfunction (Also Called Impotence.)
- Open Tag Directory > Erectile Dysfunction (Also Called Impotence.)
- Podzy > Erectile Dysfunction (Also Called Impotence.)
- Yahoo > Erectile Dysfunction (Also Called Impotence.)
Mens Health Topics
Everything you need to know about Mens Health
Mens Health
If you know the Mens Health Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Mens-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.